Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Corrigendum to "TGF-β1 targets a microRNA network that regulates cellular adhesion and migration in renal cancer" [Canc. Lett. 412 (2018) 155-169].

Bogusławska J, Rodzik K, Popławski P, Kędzierska H, Rybicka B, Sokół E, Tański Z, Piekiełko-Witkowska A.

Cancer Lett. 2020 Jan 28. pii: S0304-3835(20)30014-8. doi: 10.1016/j.canlet.2020.01.006. [Epub ahead of print] No abstract available.

PMID:
32005526
2.

TGF-β and microRNA Interplay in Genitourinary Cancers.

Boguslawska J, Kryst P, Poletajew S, Piekielko-Witkowska A.

Cells. 2019 Dec 12;8(12). pii: E1619. doi: 10.3390/cells8121619. Review.

3.

MicroRNA-Mediated Metabolic Reprograming in Renal Cancer.

Bogusławska J, Popławski P, Alseekh S, Koblowska M, Iwanicka-Nowicka R, Rybicka B, Kędzierska H, Głuchowska K, Hanusek K, Tański Z, Fernie AR, Piekiełko-Witkowska A.

Cancers (Basel). 2019 Nov 20;11(12). pii: E1825. doi: 10.3390/cancers11121825.

4.

Thyroid Hormones and Cancer: A Comprehensive Review of Preclinical and Clinical Studies.

Krashin E, Piekiełko-Witkowska A, Ellis M, Ashur-Fabian O.

Front Endocrinol (Lausanne). 2019 Feb 13;10:59. doi: 10.3389/fendo.2019.00059. eCollection 2019. Review.

5.

microRNA-mediated regulation of splicing factors SRSF1, SRSF2 and hnRNP A1 in context of their alternatively spliced 3'UTRs.

Sokół E, Kędzierska H, Czubaty A, Rybicka B, Rodzik K, Tański Z, Bogusławska J, Piekiełko-Witkowska A.

Exp Cell Res. 2018 Feb 15;363(2):208-217. doi: 10.1016/j.yexcr.2018.01.009. Epub 2018 Jan 10.

PMID:
29331391
6.

Restoration of type 1 iodothyronine deiodinase expression in renal cancer cells downregulates oncoproteins and affects key metabolic pathways as well as anti-oxidative system.

Popławski P, Wiśniewski JR, Rijntjes E, Richards K, Rybicka B, Köhrle J, Piekiełko-Witkowska A.

PLoS One. 2017 Dec 22;12(12):e0190179. doi: 10.1371/journal.pone.0190179. eCollection 2017.

7.

TGF-β1 targets a microRNA network that regulates cellular adhesion and migration in renal cancer.

Bogusławska J, Rodzik K, Popławski P, Kędzierska H, Rybicka B, Sokół E, Tański Z, Piekiełko-Witkowska A.

Cancer Lett. 2018 Jan 1;412:155-169. doi: 10.1016/j.canlet.2017.10.019. Epub 2017 Oct 25. Erratum in: Cancer Lett. 2020 Jan 28;:.

PMID:
29079415
8.

The significance of TRIP11 and T3 signalling pathway in renal cancer progression and survival of patients.

Popławski P, Piekiełko-Witkowska A, Nauman A.

Endokrynol Pol. 2017;68(6):631-641. doi: 10.5603/EP.a2017.0052. Epub 2017 Oct 12.

PMID:
29022645
9.

Protein kinases that phosphorylate splicing factors: Roles in cancer development, progression and possible therapeutic options.

Czubaty A, Piekiełko-Witkowska A.

Int J Biochem Cell Biol. 2017 Oct;91(Pt B):102-115. doi: 10.1016/j.biocel.2017.05.024. Epub 2017 May 25. Review.

PMID:
28552434
10.

The role of SRSF1 in cancer.

Sokół E, Bogusławska J, Piekiełko-Witkowska A.

Postepy Hig Med Dosw (Online). 2017 May 17;71(0):422-430. Review.

11.

Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer.

Kędzierska H, Piekiełko-Witkowska A.

Cancer Lett. 2017 Jun 28;396:53-65. doi: 10.1016/j.canlet.2017.03.013. Epub 2017 Mar 14. Review.

PMID:
28315432
12.

Integrated transcriptomic and metabolomic analysis shows that disturbances in metabolism of tumor cells contribute to poor survival of RCC patients.

Popławski P, Tohge T, Bogusławska J, Rybicka B, Tański Z, Treviño V, Fernie AR, Piekiełko-Witkowska A.

Biochim Biophys Acta Mol Basis Dis. 2017 Mar;1863(3):744-752. doi: 10.1016/j.bbadis.2016.12.011. Epub 2016 Dec 22.

13.

Induction of type 1 iodothyronine deiodinase expression inhibits proliferation and migration of renal cancer cells.

Poplawski P, Rybicka B, Boguslawska J, Rodzik K, Visser TJ, Nauman A, Piekielko-Witkowska A.

Mol Cell Endocrinol. 2017 Feb 15;442:58-67. doi: 10.1016/j.mce.2016.12.004. Epub 2016 Dec 8.

PMID:
27940296
14.

microRNAs target SRSF7 splicing factor to modulate the expression of osteopontin splice variants in renal cancer cells.

Boguslawska J, Sokol E, Rybicka B, Czubaty A, Rodzik K, Piekielko-Witkowska A.

Gene. 2016 Dec 31;595(2):142-149. doi: 10.1016/j.gene.2016.09.031. Epub 2016 Sep 21.

PMID:
27664584
15.

Decreased Expression of SRSF2 Splicing Factor Inhibits Apoptotic Pathways in Renal Cancer.

Kędzierska H, Popławski P, Hoser G, Rybicka B, Rodzik K, Sokół E, Bogusławska J, Tański Z, Fogtman A, Koblowska M, Piekiełko-Witkowska A.

Int J Mol Sci. 2016 Sep 28;17(10). pii: E1598.

16.

Expression of Genes Involved in Cellular Adhesion and Extracellular Matrix Remodeling Correlates with Poor Survival of Patients with Renal Cancer.

Boguslawska J, Kedzierska H, Poplawski P, Rybicka B, Tanski Z, Piekielko-Witkowska A.

J Urol. 2016 Jun;195(6):1892-902. doi: 10.1016/j.juro.2015.11.050. Epub 2015 Nov 26.

PMID:
26631499
17.

Epigenetic regulation of thyroid hormone receptor beta in renal cancer.

Wojcicka A, Piekielko-Witkowska A, Kedzierska H, Rybicka B, Poplawski P, Boguslawska J, Master A, Nauman A.

PLoS One. 2014 May 21;9(5):e97624. doi: 10.1371/journal.pone.0097624. eCollection 2014.

18.

Alternative splicing of iodothyronine deiodinases in pituitary adenomas. Regulation by oncoprotein SF2/ASF.

Piekielko-Witkowska A, Kedzierska H, Poplawski P, Wojcicka A, Rybicka B, Maksymowicz M, Grajkowska W, Matyja E, Mandat T, Bonicki W, Nauman P.

Biochim Biophys Acta. 2013 Jun;1832(6):763-72. doi: 10.1016/j.bbadis.2013.02.013. Epub 2013 Feb 24.

19.

[Disturbances of alternative splicing in cancer].

Wiszomirska H, Piekiełko-Witkowska A, Nauman A.

Postepy Biochem. 2011;57(3):257-65. Review. Polish.

PMID:
22235651
20.

MiR-224 targets the 3'UTR of type 1 5'-iodothyronine deiodinase possibly contributing to tissue hypothyroidism in renal cancer.

Boguslawska J, Wojcicka A, Piekielko-Witkowska A, Master A, Nauman A.

PLoS One. 2011;6(9):e24541. doi: 10.1371/journal.pone.0024541. Epub 2011 Sep 2.

Supplemental Content

Loading ...
Support Center